Stocks to buy

Thanks to both Canadian legalization as well as the 2018 farm bill here in the states, North America has essentially become “little Amsterdam.” Moreover, favorably shifting public sentiment in the U.S. has made cannabis-infused beverage companies like New Age Beverages (NASDAQ:NBEV) intriguing for both consumers and investors alike. Particularly, NBEV stock appeals for the underlying
0 Comments
Apple (NASDAQ:AAPL) is a company that’s more than four decades old and has a market capitalization north of $1.1 trillion, the latter factoid confirming the iPhone maker’s status as a story stock. The California-based company continues writing chapters to that story and, more importantly, investors keep benefiting. Source: Shutterstock Much of Apple’s success is attributable
0 Comments
U.S. equities have enjoyed a surge to new record highs this week amid burgeoning hopes that the Trump Administration will finally land a new trade deal with China. The chatter is that the United States is now willing to roll back trade tariffs to secure an agreement, something Beijing feels is a necessary precondition to
0 Comments
All stocks correct. It’s also a fact that growth stocks come and go. But sometimes Wall Street’s cautious dismissal of future prospects can lead to big-time profits. And right now Abiomed (NASDAQ:ABMD), Ulta Beauty Salon (NASDAQ:ULTA) and Baidu (ADR) (NASDAQ:BIDU) are three former dearly-held companies that maintain growth stock potential and bottoms ready for purchase.
0 Comments
[Editor’s note: “10 Medical Marijuana Stocks to Cure Your Portfolio” was previously published in October 2019. It has since been updated to include the most relevant information available.] Invariably, no other investment class generates as much interest and controversy as marijuana stocks. Within a generation, public sentiment toward legalization shifted dramatically from strongly opposed to
0 Comments
Back in mid-July, I wrote on InvestorPlace that it looked like shares of beaten up pharmacy retailer CVS (NYSE:CVS) were ready to breakout higher. The headwinds, which had plunged shares into dirt-cheap territory, were going to ease going forward, meaning that there was no reason for the dirt-cheap valuation to stick around. Source: Shutterstock Fast
0 Comments
PayPal (NASDAQ:PYPL) closed its first day as a publicly traded company on July 20, 2015, at $40.47 a share. On Jan. 9, 2018, PayPal stock went over $80 for the first time, doubling the PYPL stock price in approximately 30 months. Source: JHVEPhoto / Shutterstock.com For PYPL stock to double a second time, PayPal, the
0 Comments
U.S. equities are rallying to fresh record highs on Monday thanks, yet again, to positive China trade headlines right before the open. The focus is shifting from whether a deal actually gets done — as well as specifics around thorny issues like intellectual property protection — to where President Donald Trump would like to get
0 Comments
U.S. equities, including transportation stocks, were rallying to new record highs on Friday, pushing the S&P 500 up and over the 3,050 level for the first time. The move exits a long consolidation range going back to July and comes in the wake of better-than-expected employment data and a better-than-feared manufacturing report for October. Nonfarm
0 Comments
Shares of Etsy (NASDAQ:ETSY) plunged in late October after the specialty e-retailer reported mixed third-quarter numbers that included a lame fourth-quarter guide. The broad implication? The Etsy growth narrative is slowing, with the revenue growth trajectory flattening out and margins starting to come under pressure. Source: quietbits / Shutterstock.com Heading into the print, ETSY stock
0 Comments
Salesforce (NYSE:CRM) CEO Marc Benioff recently declared that capitalism is dead, suggesting that America “[Needs] a new, more sustainable, more equitable, more fair capitalism.” Benioff’s company is one of 193 American businesses that have signed the Business Roundtable’s Statement on the Purpose of a Corporation that highlight’s the need for companies to address all the
0 Comments